International Journal of Molecular Sciences,
Год журнала:
2024,
Номер
25(20), С. 11040 - 11040
Опубликована: Окт. 14, 2024
The
European
olive
tree,
Olea
europaea
L.,
and
its
polyphenols
hold
great
therapeutic
potential
to
treat
neuroinflammation
cognitive
impairment.
This
review
examines
the
evidence
for
anti-inflammatory
neuroprotective
actions
of
their
in
treatment
long
COVID
neurodegenerative
diseases
such
as
Alzheimer’s
disease
(AD),
Parkinson’s
(PD),
multiple
sclerosis
(MS).
Key
findings
suggest
that
exhibit
antioxidant,
anti-inflammatory,
neuroprotective,
antiviral
properties,
making
them
promising
candidates
intervention,
especially
when
formulated
unique
combinations.
Recommendations
future
research
directions
include
elucidating
molecular
pathways
through
mechanistic
studies,
exploring
implications
polyphenol
supplementation,
conducting
clinical
trials
assess
efficacy
safety.
Investigating
synergistic
effects
with
other
agents
addressing
different
targets
is
suggested
further
exploration.
reviewed
strengthens
translational
value
conditions
involving
dysfunction
emphasizes
novelty
new
formulations.
Life,
Год журнала:
2024,
Номер
14(9), С. 1076 - 1076
Опубликована: Авг. 28, 2024
Background:
The
term
“Long
COVID”
is
commonly
used
to
describe
persisting
symptoms
after
acute
COVID-19.
Until
now,
proposed
mechanisms
for
the
explanation
of
Long
COVID
have
not
related
quantitative
measurements
basic
laws.
In
this
work,
a
common
framework
pathophysiological
mechanism
presented,
based
on
blood
supply
deprivation
and
flow
diffusion
equation.
Methods:
Case–control
studies
with
statistically
significant
differences
between
cases
(post-COVID
patients)
controls,
from
multiple
tissues
geographical
areas,
were
gathered
tabulated.
Microvascular
loss
(ML)
was
quantified
by
vessel
density
reduction
(VDR),
foveal
avascular
zone
enlargement
(FAZE),
capillary
(CDR),
percentage
perfused
(PPVR).
Both
ML
hemodynamic
decrease
(HD)
incorporated
in
tissue
(SR)
estimation.
Results:
data
found
763
post-COVID
patients
an
average
VDR,
FAZE,
CDR,
PPVR
16%,
31%,
14%,
21%,
respectively.
HD
72
37%.
estimated
SR
634
reached
sizeable
47%.
This
large
creates
conditions
lower
mass
rates,
hypoxia,
undernutrition,
which
at
multi-tissue
level,
long
time,
can
explain
wide
variety
symptoms.
Conclusions:
Disruption
peripheral
contribution
both
here
be
principal
cause
leading
medRxiv (Cold Spring Harbor Laboratory),
Год журнала:
2024,
Номер
unknown
Опубликована: Март 14, 2024
Abstract
In
this
study,
we
analyzed
the
potential
associations
of
selected
laboratory
and
anamnestic
parameters,
as
well
12
genetic
polymorphisms
(SNPs),
with
clinical
COVID-19
occurrence
severity
in
869
hospitalized
patients.
The
SNPs
by
qPCR
were
based
on
population-wide
(GWAS)
data
previously
indicating
association
COVID-19.
We
confirmed
disease
several
parameters
found
an
unexpected
between
less
severe
loss
smell
taste.
most
cases,
SNP
analysis
supported
earlier
results
hospitalization
severity,
while
role
some
unrecognized
has
also
been
observed.
A
was
indicated
presence
a
reduced-function
ABCG2
transporter
variant
disease,
which
observed
diabetic
Our
current
results,
should
be
reinforced
larger
studies,
indicate
that
together
may
have
predictive
value
for
International Journal of Molecular Sciences,
Год журнала:
2024,
Номер
25(20), С. 11040 - 11040
Опубликована: Окт. 14, 2024
The
European
olive
tree,
Olea
europaea
L.,
and
its
polyphenols
hold
great
therapeutic
potential
to
treat
neuroinflammation
cognitive
impairment.
This
review
examines
the
evidence
for
anti-inflammatory
neuroprotective
actions
of
their
in
treatment
long
COVID
neurodegenerative
diseases
such
as
Alzheimer’s
disease
(AD),
Parkinson’s
(PD),
multiple
sclerosis
(MS).
Key
findings
suggest
that
exhibit
antioxidant,
anti-inflammatory,
neuroprotective,
antiviral
properties,
making
them
promising
candidates
intervention,
especially
when
formulated
unique
combinations.
Recommendations
future
research
directions
include
elucidating
molecular
pathways
through
mechanistic
studies,
exploring
implications
polyphenol
supplementation,
conducting
clinical
trials
assess
efficacy
safety.
Investigating
synergistic
effects
with
other
agents
addressing
different
targets
is
suggested
further
exploration.
reviewed
strengthens
translational
value
conditions
involving
dysfunction
emphasizes
novelty
new
formulations.